கோடாய் குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from கோடாய் குழு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In கோடாய் குழு Today - Breaking & Trending Today
Fresh dispute brews in Khoday Group May 25, 2021 FIR claims ₹1,222 cr embezzled from group’s trust A fresh dispute has surfaced between two factions of the family members of the Khoday Group, the country’s oldest liquor company. A faction led by Padmanabhasa Khoday, one of the four brothers who own stakes in the Khoday Group, has filed an FIR in a police station in Bengaluru accusing his brother KL Swamy and his two sons and a finance manager of the Khoday Group of embezzling funds and assets worth ₹1,222 crore in the family’s LK Trust. The FIR states that KL Swamy was nominated as the managing trustee of LK Trust. However, by virtue of misrepresentation and by deceiving the complainant and beneficiaries of the trust, a supplemental deed was executed in 2011 by altering the basic structure of the original trust deed without the consent and approval of the beneficiaries, the FIR states. ....
Khoday s Viranorm, Latest Ayurvedic Immunity Boosting Antiviral Drug For COVID Treatment May 17, 2021, 18:59 IST The Khoday Group has released an ayurvedic medication for the treatment of Covid. Bengaluru: Bengaluru-based Khoday Group has developed an ayurvedic immunity-boosting drug that is currently being tested in various hospitals. Around 250 Covid patients are currently being screened on ViraNorm in Victoria and other hospitals. The third stage of the trial for ViraNorm, which was produced in collaboration with Althea DRF and Lifesciences, has been completed. In the presence of Dr. K G Padmanabhan and Dr. Radhashyam Naik, Khoday Group managing director Swamy Khoday published ViraNorm in tablet shape on Saturday. ....
The drug is add-on therapy for asymptomatic and symptomatic Covid patients. Khoday Group of Industries, a Bengaluru based company, has rolled out ViraNorm - ayurvedic immuno-modulator, which helps treat Covid-19 patients. Through the launch of ‘ViraNorm’, Khoday Group is entering the alternative medicine sector. The drug ‘ViraNorm’ has been developed by Khoday Group in collaboration with Athera Dabur Research Foundation (DRF) LifeSciences. According to the company, ‘ViraNorm’ has undergone Phase 3 clinical trials in the country for an ayurvedic formulation and conducted according to international standards of good clinical trials and is found to be effective in clinical trials and has been launched after subjecting it, thorough efficacy and safety studies. It helps to halt the progression of viruses in the body. So, this can be referred as an add-on therapy/medication for asymptomatic and symptomatic Covid patients. This helps in stopping the migration ....
Text by Sushmita Sundaram. Photographed by Wamika Gera Amrut Distilleries shook up the scene in 2010 when their flagship single malt won global recognition in Jim Murray’s Whisky Bible as the third-best whisky in the world. Ten years on, home-grown single malts are still fighting for a seat at the table, where Amrut has set the gold standard One evening in November last year, whisky experts from across the world gathered over a Zoom call to celebrate the launch of Bengaluru-based Amrut Distilleries’ latest single malt, Fusion X. Despite the video glitches and crackling audio, the mood was convivial. Whisky connoisseurs from Bengaluru rubbed virtual elbows with Scottish distillers whose families had been in the business for centuries. ....